Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.

Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells

Open access
Hansel, Christine, Barr, Samantha, Schemann, Alina V., Lauber, Kirsten, Hess, Julia, Unger, Kristian, Zitzelsberger, Horst, Jendrossek, Verena, Klein, Diana · 2021 · International Journal of Molecular Sciences

Abstract

Radiation-induced damage to normal lung parenchyma remains a dose-limiting factor in thorax-associated radiotherapy (RT). Severe early and late complications with lungs can increase the risk of morbidity in cancer patients after RT. Herein, senescence of lung epithelial cells following RT-induced cellular stress, or more precisely the respective altered secretory profile, the senescence-associated secretory phenotype (SASP), was suggested as a central process for the initiation and progression of pneumonitis and pulmonary fibrosis. We previously reported that abrogation of certain aspects of the secretome of senescent lung cells, in particular, signaling inhibition of the SASP-factor Ccl2/Mcp1 mediated radioprotection especially by limiting endothelial dysfunction. Here, we investigated the therapeutic potential of a combined metformin treatment to protect normal lung tissue from RT-induced senescence and associated lung injury using a preclinical mouse model of radiation-induced pneumopathy. Metformin treatment efficiently limited RT-induced senescence and SASP expression levels, thereby limiting vascular dysfunctions, namely increased vascular permeability associated with increased extravasation of circulating immune and tumor cells early after irradiation (acute effects). Complementary in vitro studies using normal lung epithelial cell lines confirmed the senescence-limiting effect of metformin following RT finally resulting in radioprotection, while fostering RT-induced cellular stress of cultured malignant epithelial cells accounting for radiosensitization. The radioprotective action of metformin for normal lung tissue without simultaneous protection or preferable radiosensitization of tumor tissue might increase tumor control probabilities and survival because higher radiation doses could be used.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22137064

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Metformin treatment limits senescence of bronchial–alveolar epithelial cells and associated senescence associated secretory phenotype in whole thorax irradiated mice. (A) C57BL/6 mice were left untreated (Ctrl), received five-times a week metformin (Met) treatment, 15Gy whole thorax irradiation (WTI) or received WTI in combination five-times a week metformin treatment for first three weeks post WTI. (B) Senescence-associated beta-galactosidase activity was analyzed on frozen lung sections, 21 days post irradiation. Photomicrographs depict representative pictures (scale bar = 200 µm). (C) Senescence mediator cyclin-dependent kinase inhibitor 1 (Cdkn1a/p21) protein expressions were analyzed in whole lung protein lysates using Western Blot analyses Expression levels were quantified by densitometry and data are presented as mean values ±SEM of individual biological replicates (n = 6–9 per group). p-values indicate: ** p ≤ 0.01 by one-way ANOVA with post hoc Tukey’s multiple comparison test. (D) Cdkn1a/p21 as well as cyclin D1 (Ccnd1) mRNA expression levels were further quantified using Real-Time RT-PCR. Relative transcript levels were normalized to beta-actin (set as 1). Symbols depict individual biological replicates measured in duplicates each (0Gy and 15Gy Ctrl: n = 9 per group; 0Gy Met, 15Gy Met: n = 6 per group). Data represent mean values ±SEM, p-values indicate: * p ≤ 0.05, ** p ≤ 0.01 by one-way ANOVA with post hoc Tukey’s multiple comparison test. Additional unpaired (two-tailed) t-test analysis is depicted by # p ≤ 0.05. (E) SASP factor (Ccl2, Mmp2, Cxcl1, Il6, Ccl7, Ccl8) expression levels were analyzed (in duplicates) on mRNA level of whole lung RNA isolates (0Gy and 15Gy Ctrl: n = 9 per group; 0Gy Met, 15Gy Met: n = 6 per group). Individual biological replicates and mean values ±SEM are shown. p-values indicate: * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001 by one-way ANOVA with post hoc Tukey’s multiple comparison test and additionally by unpaired (two-tailed) t-tests as depicted by ## p ≤ 0.01, ### p ≤ 0.001.
Figure 1 Metformin treatment limits senescence of bronchial–alveolar epithelial cells and associated senescence associated secretory phenotype in whole thorax irradiated mice. (A) C57BL/6 mice were left untreated (Ctrl), received five-times a week metformin (Met) treatment, 15Gy whole thorax irradiation (WTI) or received WTI in combination five-times a week metformin treatment for first three weeks post WTI. (B) Senescence-associated beta-galactosidase activity was analyzed on frozen lung sections, 21 days post irradiation. Photomicrographs depict representative pictures (scale bar = 200 µm). (C) Senescence mediator cyclin-dependent kinase inhibitor 1 (Cdkn1a/p21) protein expressions were analyzed in whole lung protein lysates using Western Blot analyses Expression levels were quantified by densitometry and data are presented as mean values ±SEM of individual biological replicates (n = 6–9 per group). p-values indicate: ** p ≤ 0.01 by one-way ANOVA with post hoc Tukey’s multiple comparison test. (D) Cdkn1a/p21 as well as cyclin D1 (Ccnd1) mRNA expression levels were further quantified using Real-Time RT-PCR. Relative transcript levels were normalized to beta-actin (set as 1). Symbols depict individual biological replicates measured in duplicates each (0Gy and 15Gy Ctrl: n = 9 per group; 0Gy Met, 15Gy Met: n = 6 per group). Data represent mean values ±SEM, p-values indicate: * p ≤ 0.05, ** p ≤ 0.01 by one-way ANOVA with post hoc Tukey’s multiple comparison test. Additional unpaired (two-tailed) t-test analysis is depicted by # p ≤ 0.05. (E) SASP factor (Ccl2, Mmp2, Cxcl1, Il6, Ccl7, Ccl8) expression levels were analyzed (in duplicates) on mRNA level of whole lung RNA isolates (0Gy and 15Gy Ctrl: n = 9 per group; 0Gy Met, 15Gy Met: n = 6 per group). Individual biological replicates and mean values ±SEM are shown. p-values indicate: * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001 by one-way ANOVA with post hoc Tukey’s multiple comparison test and additionally by unpaired (two-tailed) t-tests as depicted by ## p ≤ 0.01, ### p ≤ 0.001.CC BY · PubMed Central
Figure 2 Metformin treatment counteracts radiation-induced vascular dysfunction (acute effect) and recruitment of inflammatory myeloid cells. C57BL/6 mice were left untreated (Ctrl), received five-times a week metformin (Met) treatment, 15Gy WTI, or received WTI in combination five-times a week metformin treatment for first three weeks post WTI. (A) Three weeks post irradiation, vascular leakage was determined by intravenously injected Evans Blue dye (EBD) extravasation from the blood stream to the lung interstitium. Extracted EBD concentrations were quantified by absorption measurements and related to lung weight. Symbols represent biological replicates (0Gy Ctrl: n = 7; 15Gy Ctrl: n = 9; 0Gy Met: n = 5, 15Gy Met: n = 8) with indicated mean values ±SEM. p-values indicate * p ≤ 0.05, *** p ≤ 0.001 by one-way ANOVA with post hoc Tukey’s multiple comparison test. (B) Endothelial marker expression in crude cell extracts of freshly isolated lung tissue were identified using CD31/PECAM1, CD34 and VEGFR2 expressions (of CD45 negative cells) by flow cytometry. Symbols depict individual biological replicates (n = 6 for each group) with indicated mean values ±SEM. p-values indicate: * p ≤ 0.05 by one-way ANOVA with post hoc Tukey’s multiple comparison test. (C) Leukocytes were identified using CD45 expression and myeloid cells were further characterized using CD11b and CD11c antibodies. Alveolar macrophages (AM) measured as CD11c(high)CD11b(intermediate) cells, CD11b(+)CD11c(-) myeloid cells (monocytes/granulocytes) and CD11b(high)CD11c(intermediate) phagocytic cells are depicted as symbols (individual biological replicates) with mean values ±SEM. p-values indicate: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by one-way ANOVA with post hoc Tukey’s multiple comparison test and additionally by unpaired (two-tailed) t-tests depicted as # p ≤ 0.05.
Figure 2 Metformin treatment counteracts radiation-induced vascular dysfunction (acute effect) and recruitment of inflammatory myeloid cells. C57BL/6 mice were left untreated (Ctrl), received five-times a week metformin (Met) treatment, 15Gy WTI, or received WTI in combination five-times a week metformin treatment for first three weeks post WTI. (A) Three weeks post irradiation, vascular leakage was determined by intravenously injected Evans Blue dye (EBD) extravasation from the blood stream to the lung interstitium. Extracted EBD concentrations were quantified by absorption measurements and related to lung weight. Symbols represent biological replicates (0Gy Ctrl: n = 7; 15Gy Ctrl: n = 9; 0Gy Met: n = 5, 15Gy Met: n = 8) with indicated mean values ±SEM. p-values indicate * p ≤ 0.05, *** p ≤ 0.001 by one-way ANOVA with post hoc Tukey’s multiple comparison test. (B) Endothelial marker expression in crude cell extracts of freshly isolated lung tissue were identified using CD31/PECAM1, CD34 and VEGFR2 expressions (of CD45 negative cells) by flow cytometry. Symbols depict individual biological replicates (n = 6 for each group) with indicated mean values ±SEM. p-values indicate: * p ≤ 0.05 by one-way ANOVA with post hoc Tukey’s multiple comparison test. (C) Leukocytes were identified using CD45 expression and myeloid cells were further characterized using CD11b and CD11c antibodies. Alveolar macrophages (AM) measured as CD11c(high)CD11b(intermediate) cells, CD11b(+)CD11c(-) myeloid cells (monocytes/granulocytes) and CD11b(high)CD11c(intermediate) phagocytic cells are depicted as symbols (individual biological replicates) with mean values ±SEM. p-values indicate: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by one-way ANOVA with post hoc Tukey’s multiple comparison test and additionally by unpaired (two-tailed) t-tests depicted as # p ≤ 0.05.CC BY · PubMed Central
Figure 3 Metformin treatment limits metastasis formation in previously irradiated lung tissue. (A) C57BL/6 mice were left untreated (Ctrl), received metformin (Met) treatment, 15Gy WTI or received WTI in combination with metformin (Met) treatment for first three weeks post WTI. (B) Seeding of circulating tumor cells into the lungs was initiated 21 days after irradiation. Therefore, 0.5 × 10(6) metastatic tumor cells were intravenously transplanted via the tail vein of C57BL/6 mice. Fourteen days after tumor cell injection animals were sacrificed, lungs were isolated and subjected for lung histopathology using hematoxylin and eosin staining. Areas of extravasated tumor cells were emphasized by asterisks (B1, B3). Arrows point towards formed metastases (B1, B4). Scale bar: 200 µm; magnifications: 40 µm. (C) Sites of vascular leakage (designated as sites of tumor cell extravasation/micrometastasis) and (D) subsequently formed macrometastasis were quantified in whole lung sections (0Gy Ctrl, 0Gy Met, 15Gy Met: n = 7 per group; 15Gy ctrl: n = 6). Data are shown as individual biological replicates with mean values ±SEM. p-values indicate: * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001 by one-way ANOVA with post hoc Tukey’s multiple comparison test.
Figure 3 Metformin treatment limits metastasis formation in previously irradiated lung tissue. (A) C57BL/6 mice were left untreated (Ctrl), received metformin (Met) treatment, 15Gy WTI or received WTI in combination with metformin (Met) treatment for first three weeks post WTI. (B) Seeding of circulating tumor cells into the lungs was initiated 21 days after irradiation. Therefore, 0.5 × 10(6) metastatic tumor cells were intravenously transplanted via the tail vein of C57BL/6 mice. Fourteen days after tumor cell injection animals were sacrificed, lungs were isolated and subjected for lung histopathology using hematoxylin and eosin staining. Areas of extravasated tumor cells were emphasized by asterisks (B1, B3). Arrows point towards formed metastases (B1, B4). Scale bar: 200 µm; magnifications: 40 µm. (C) Sites of vascular leakage (designated as sites of tumor cell extravasation/micrometastasis) and (D) subsequently formed macrometastasis were quantified in whole lung sections (0Gy Ctrl, 0Gy Met, 15Gy Met: n = 7 per group; 15Gy ctrl: n = 6). Data are shown as individual biological replicates with mean values ±SEM. p-values indicate: * p ≤ 0.05, ** p ≤ 0.01, **** p ≤ 0.0001 by one-way ANOVA with post hoc Tukey’s multiple comparison test.CC BY · PubMed Central
Figure 4 Metformin treatment does not impact on proliferation and survival of normal epithelial lung cell cultures following RT. Lung epithelial cell lines derived from normal lung epithelium (BEAS-2B: human bronchial epithelial cells, (A–C); HSAEC1-KT: human small airway epithelial cells, (D–F)) were cultured in normal growth media supplemented with metformin (2 and 10 mM) or vehicle control (Ctrl) 2 h prior radiation treatment with 0Gy or 15Gy. Cell cycle phases (A,D) and apoptotic cells (SubG1) (B,E) were analyzed by flow cytometry 96 h after irradiation. Graphs consist of data from 3–5 individual experiments (with SEM). p-values indicate: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by two-way ANOVA with Tukey’s multiple comparison test. (C,F) Clonogenic survival was evaluated in metformin treated (0, 2, 10 mM) and irradiated (0, 2, 4, 6 Gy) in BEAS-2B and HSAEC1-KT cells at 10 days post RT. Coomassie stained colonies were quantified by counting. Data show the surviving fractions (SF) from 3 independent experiments (means ±SEM) plated in triplicates each. p-values indicate: * p ≤ 0.05, by one-way ANOVA with Tukey’s multiple comparison test. Cell viability was analyzed using WST-1 assay in BEAS-2B (G) and HSAEC1-KT (I) cells at 96 h post treatment. Cell proliferation was further determined using crystal violet staining (H,J). Data represent mean values ±SEM from 4–5 independent experiments measured in seven replicates each. p-values indicate: ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by two-way ANOVA with Tukey’s multiple comparison test.
Figure 4 Metformin treatment does not impact on proliferation and survival of normal epithelial lung cell cultures following RT. Lung epithelial cell lines derived from normal lung epithelium (BEAS-2B: human bronchial epithelial cells, (A–C); HSAEC1-KT: human small airway epithelial cells, (D–F)) were cultured in normal growth media supplemented with metformin (2 and 10 mM) or vehicle control (Ctrl) 2 h prior radiation treatment with 0Gy or 15Gy. Cell cycle phases (A,D) and apoptotic cells (SubG1) (B,E) were analyzed by flow cytometry 96 h after irradiation. Graphs consist of data from 3–5 individual experiments (with SEM). p-values indicate: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by two-way ANOVA with Tukey’s multiple comparison test. (C,F) Clonogenic survival was evaluated in metformin treated (0, 2, 10 mM) and irradiated (0, 2, 4, 6 Gy) in BEAS-2B and HSAEC1-KT cells at 10 days post RT. Coomassie stained colonies were quantified by counting. Data show the surviving fractions (SF) from 3 independent experiments (means ±SEM) plated in triplicates each. p-values indicate: * p ≤ 0.05, by one-way ANOVA with Tukey’s multiple comparison test. Cell viability was analyzed using WST-1 assay in BEAS-2B (G) and HSAEC1-KT (I) cells at 96 h post treatment. Cell proliferation was further determined using crystal violet staining (H,J). Data represent mean values ±SEM from 4–5 independent experiments measured in seven replicates each. p-values indicate: ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by two-way ANOVA with Tukey’s multiple comparison test.CC BY · PubMed Central
Figure 5 Metformin treatment prevents RT-induced senescence in normal epithelial lung cell cultures. The impact of metformin treatment for RT-induced senescence formation was investigated in cultures of lung epithelial cell lines derived from normal lung epithelium (BEAS-2B and HSAEC1-KT) by analyzing protein expression levels of senescence markers via Western blot (A,E), C12FDG staining and flow cytometry (B,F), and SA-betagal activity staining (C,D,G,H). p21 and p53 expression levels and respective levels of the cell survival marker AKT/PKB were analyzed by Western Blots at 96 h post RT and treatment in BEAS-2B (A) and HSAEC1-KT (E) cells. Representative blots of 3 independent experiments are shown. Dashed lines indicate different areas of the same blot. Radiation-induced senescence formation was analyzed by C12FDG treatment prior flow cytometric analyses in BEAS-2B (B) and HSAEC1-KT (F), eight days post treatment. Data showed mean values ±SEM of six independent experiments. p-values indicate: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 by two-way ANOVA with post hoc Tukey’s multiple comparison test. Following SA-betagal activity staining, senescent BEAS-2B (C) and HSAEC1-KT (G) cells were visualized in in blue. Representative pictures are shown (scale bar: 200 µm). (D,H) Senescence formation was quantified by counting the numbers of SA-betagal-positive and -negative epithelial cells. Data showed mean values ±SEM of 3–5 independent experiments. p-value indicates: * p ≤ 0.05 by two-way ANOVA with Tukey’s multiple comparison test.
Figure 5 Metformin treatment prevents RT-induced senescence in normal epithelial lung cell cultures. The impact of metformin treatment for RT-induced senescence formation was investigated in cultures of lung epithelial cell lines derived from normal lung epithelium (BEAS-2B and HSAEC1-KT) by analyzing protein expression levels of senescence markers via Western blot (A,E), C12FDG staining and flow cytometry (B,F), and SA-betagal activity staining (C,D,G,H). p21 and p53 expression levels and respective levels of the cell survival marker AKT/PKB were analyzed by Western Blots at 96 h post RT and treatment in BEAS-2B (A) and HSAEC1-KT (E) cells. Representative blots of 3 independent experiments are shown. Dashed lines indicate different areas of the same blot. Radiation-induced senescence formation was analyzed by C12FDG treatment prior flow cytometric analyses in BEAS-2B (B) and HSAEC1-KT (F), eight days post treatment. Data showed mean values ±SEM of six independent experiments. p-values indicate: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 by two-way ANOVA with post hoc Tukey’s multiple comparison test. Following SA-betagal activity staining, senescent BEAS-2B (C) and HSAEC1-KT (G) cells were visualized in in blue. Representative pictures are shown (scale bar: 200 µm). (D,H) Senescence formation was quantified by counting the numbers of SA-betagal-positive and -negative epithelial cells. Data showed mean values ±SEM of 3–5 independent experiments. p-value indicates: * p ≤ 0.05 by two-way ANOVA with Tukey’s multiple comparison test.CC BY · PubMed Central
Figure 6 RT-induced cellular stress is reduced upon combined metformin treatment in epithelial cells established from normal lung epithelium. BEAS-2B (A,B) and HSAEC1-KT (C,D) lung epithelial cells were analyzed concerning reactive oxygen species (ROS) production (A,C) at 24 h of post RT and metformin (Met) treatment using dihydroethidium staining in combination with flow cytometry analyses. Data are shown as mean values ±SEM of 5–7 independent experiments. p-value indicates: **** p ≤ 0.0001 by two-way ANOVA with post hoc Tukey’s multiple comparison test and additionally by unpaired (two-tailed) t-tests depicted as # p ≤ 0.05, ## p ≤ 0.01. Respective cell cycle analysis (B,D) at that time point were estimated following Nicoletti staining. Data are summarized as mean values ±SEM of 3–5 independent experiments.
Figure 6 RT-induced cellular stress is reduced upon combined metformin treatment in epithelial cells established from normal lung epithelium. BEAS-2B (A,B) and HSAEC1-KT (C,D) lung epithelial cells were analyzed concerning reactive oxygen species (ROS) production (A,C) at 24 h of post RT and metformin (Met) treatment using dihydroethidium staining in combination with flow cytometry analyses. Data are shown as mean values ±SEM of 5–7 independent experiments. p-value indicates: **** p ≤ 0.0001 by two-way ANOVA with post hoc Tukey’s multiple comparison test and additionally by unpaired (two-tailed) t-tests depicted as # p ≤ 0.05, ## p ≤ 0.01. Respective cell cycle analysis (B,D) at that time point were estimated following Nicoletti staining. Data are summarized as mean values ±SEM of 3–5 independent experiments.CC BY · PubMed Central
Figure 7 Metformin treatment reduces mitochondrial respiration in non-malignant epithelial lung cells. Extracellular flux analyses following (24 h after) metformin and RT treatment were performed in order to measure oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) in BEAS-2B (A–H) and HSAEC1-KT (I–P) over time, while oligomycin (Oligo; 1 µM), FCCP (1 µM) and rotenone/Antimycin A (Rot/Ant; 0.5 µM) were added at indicated time points. (A,I) OCR levels of control and irradiated lung epithelial cells are shown. (B,J) OCR levels of control and metformin treated lung epithelial cells are shown. (C,K) Decreases in OCR following the combined treatment are shown. (D,L) Basal respiration, (E,M) maximal respiration, (F,N) ATP production, and (G,O) proton leak were depicted in separate bar diagrams. (H,P) Respective ECAR measurement over time are shown. Data were summarized as mean values ± SD (measured in 4–7 replicates each). One of 3 independent experiments per epithelial cell line with similar results is shown. p-values indicate: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by one-way ANOVA with Tukey’s multiple comparison test.
Figure 7 Metformin treatment reduces mitochondrial respiration in non-malignant epithelial lung cells. Extracellular flux analyses following (24 h after) metformin and RT treatment were performed in order to measure oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) in BEAS-2B (A–H) and HSAEC1-KT (I–P) over time, while oligomycin (Oligo; 1 µM), FCCP (1 µM) and rotenone/Antimycin A (Rot/Ant; 0.5 µM) were added at indicated time points. (A,I) OCR levels of control and irradiated lung epithelial cells are shown. (B,J) OCR levels of control and metformin treated lung epithelial cells are shown. (C,K) Decreases in OCR following the combined treatment are shown. (D,L) Basal respiration, (E,M) maximal respiration, (F,N) ATP production, and (G,O) proton leak were depicted in separate bar diagrams. (H,P) Respective ECAR measurement over time are shown. Data were summarized as mean values ± SD (measured in 4–7 replicates each). One of 3 independent experiments per epithelial cell line with similar results is shown. p-values indicate: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by one-way ANOVA with Tukey’s multiple comparison test.CC BY · PubMed Central
Figure 8 Metformin treatment reduces malignant lung epithelial cell proliferation and survival following RT. Non-small cell lung cancer cells (NSCLC; NCI-H460: human epithelial large cell lung carcinoma; (A–D) and A549: human alveolar basal epithelial adenocarcinoma; (E–H)) were cultured in normal growth media supplemented with metformin (2 and 10 mM) or vehicle control (Ctrl) 2 h prior radiation treatment with 0Gy or 10Gy. Cell viability (A,E) cellular proliferation (B,F), cell cycle distributions (C,G), and cell death induction (D,H) were analyzed 96 h after the treatments. (A,E) Cell viability measurements as determined by metabolic activity using the WST-1 reagent are summarized as mean values ±SEM of 4–5 experiments, with seven replicates each. (B,F) Cellular proliferation was analyzed by crystal violet staining. Data are presented as mean values ±SEM of 5 independent experiments. p-values indicate * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by two-way ANOVA with Tukey’s multiple comparison test. (C,G) Respective cell cycle analysis at that time point were estimated following Nicoletti staining. Data were summarized as mean values ±SEM of 5–7 independent experiments. (D,H) Total cell death levels were determined by propidium iodide exclusion staining using flow cytometry. Data are summarized as mean values of 3–5 independent experiments. p-value indicate ** p ≤ 0.01 by two-way ANOVA with Tukey’s multiple comparison test. (I) Clonogenic survival was evaluated in metformin treated (0, 2, 10 mM) and irradiated (0, 2, 4, 6 Gy) NCI-H460 and A549 cells, 10 days post treatment. Coomassie stained colonies were quantified and respective surviving fractions from 3 independent experiments (means ±SEM), plated in triplicates each, were depicted. As metformin treatment dramatically reduced the plating efficiency of both NSCLC cells in a concentration-dependent manner, no colonies could be quantified here. Statistics were analyzed by unpaired (two-tailed) t-tests, comparing NCI-H460 cells to corresponding A549 cells.
Figure 8 Metformin treatment reduces malignant lung epithelial cell proliferation and survival following RT. Non-small cell lung cancer cells (NSCLC; NCI-H460: human epithelial large cell lung carcinoma; (A–D) and A549: human alveolar basal epithelial adenocarcinoma; (E–H)) were cultured in normal growth media supplemented with metformin (2 and 10 mM) or vehicle control (Ctrl) 2 h prior radiation treatment with 0Gy or 10Gy. Cell viability (A,E) cellular proliferation (B,F), cell cycle distributions (C,G), and cell death induction (D,H) were analyzed 96 h after the treatments. (A,E) Cell viability measurements as determined by metabolic activity using the WST-1 reagent are summarized as mean values ±SEM of 4–5 experiments, with seven replicates each. (B,F) Cellular proliferation was analyzed by crystal violet staining. Data are presented as mean values ±SEM of 5 independent experiments. p-values indicate * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by two-way ANOVA with Tukey’s multiple comparison test. (C,G) Respective cell cycle analysis at that time point were estimated following Nicoletti staining. Data were summarized as mean values ±SEM of 5–7 independent experiments. (D,H) Total cell death levels were determined by propidium iodide exclusion staining using flow cytometry. Data are summarized as mean values of 3–5 independent experiments. p-value indicate ** p ≤ 0.01 by two-way ANOVA with Tukey’s multiple comparison test. (I) Clonogenic survival was evaluated in metformin treated (0, 2, 10 mM) and irradiated (0, 2, 4, 6 Gy) NCI-H460 and A549 cells, 10 days post treatment. Coomassie stained colonies were quantified and respective surviving fractions from 3 independent experiments (means ±SEM), plated in triplicates each, were depicted. As metformin treatment dramatically reduced the plating efficiency of both NSCLC cells in a concentration-dependent manner, no colonies could be quantified here. Statistics were analyzed by unpaired (two-tailed) t-tests, comparing NCI-H460 cells to corresponding A549 cells.CC BY · PubMed Central
Figure 9 Metformin treatment does not impact on mitochondrial respiration in NSCLC, nor in combination with RT. Extracellular flux analyses following (24 h after) metformin and RT treatment were performed in order to measure oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) in NCI-H460 (A–E) and A549 (F–K) over time, while oligomycin (Oligo; 1 µM), FCCP (2 µM) and rotenone/Antimycin A (Rot/Ant; 0.5 µM) were added at indicated time points. (A,F) OCR levels of control and irradiated malignant epithelial cells are shown. (B,G) OCR levels of control and metformin treated malignant epithelial cells are shown. (C,H) Basal respiration and (D,I) ATP-liked respiration were depicted in separate bar diagrams. (E,K) Respective ECAR measurement over time are shown. Data are summarized as mean values ±SEM of 3 independent measured in 4–7 replicates each. p-values indicate: * p ≤ 0.05 ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by one-way ANOVA with Tukey’s multiple comparison test.
Figure 9 Metformin treatment does not impact on mitochondrial respiration in NSCLC, nor in combination with RT. Extracellular flux analyses following (24 h after) metformin and RT treatment were performed in order to measure oxygen consumption rates (OCR) and extracellular acidification rates (ECAR) in NCI-H460 (A–E) and A549 (F–K) over time, while oligomycin (Oligo; 1 µM), FCCP (2 µM) and rotenone/Antimycin A (Rot/Ant; 0.5 µM) were added at indicated time points. (A,F) OCR levels of control and irradiated malignant epithelial cells are shown. (B,G) OCR levels of control and metformin treated malignant epithelial cells are shown. (C,H) Basal respiration and (D,I) ATP-liked respiration were depicted in separate bar diagrams. (E,K) Respective ECAR measurement over time are shown. Data are summarized as mean values ±SEM of 3 independent measured in 4–7 replicates each. p-values indicate: * p ≤ 0.05 ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by one-way ANOVA with Tukey’s multiple comparison test.CC BY · PubMed Central
Figure 10 RT-induced cellular stress is increased upon combined metformin treatment in malignant lung epithelial cells. (A,E) NCI-H460 and A549 lung tumor cells were analyzed concerning reactive oxygen species (ROS) production at 24 h of post RT and metformin treatment using dihydroethidium (DHE) staining in combination with flow cytometry analyses. Data are shown as mean values ±SEM of 5–7 independent experiments. Statistics were analyzed by unpaired (two-tailed) t-tests, indicating: # p ≤ 0.05 and ## p ≤ 0.01. p-value indicates: ** p ≤ 0.01 by two-way ANOVA with post hoc Tukey’s multiple comparison test. (B,F) Respective cell cycle analysis at that time point were estimated following Nicoletti staining. Data were summarized as mean values ±SEM of 3 independent experiments. (C,G) Cell death rates were further determined by exclusion propidium iodide staining. Data show mean values ±SEM of 3 independent experiments. p-values indicate: * p ≤ 0.05, ** p ≤ 0.01 two-way ANOVA with Tukey’s multiple comparison test. Unpaired (two-tailed) t-tests are additionally indicated: # p ≤ 0.05. (D,H) Total cell death levels were determined by propidium iodide exclusion staining using flow cytometry. Data are summarized as mean values of 3–5 independent experiments. p-value indicate: * p ≤ 0.05, ** p ≤ 0.01 by two-way ANOVA with Tukey’s multiple comparison test. Unpaired (two-tailed) t-tests are additionally indicated: # p ≤ 0.05.
Figure 10 RT-induced cellular stress is increased upon combined metformin treatment in malignant lung epithelial cells. (A,E) NCI-H460 and A549 lung tumor cells were analyzed concerning reactive oxygen species (ROS) production at 24 h of post RT and metformin treatment using dihydroethidium (DHE) staining in combination with flow cytometry analyses. Data are shown as mean values ±SEM of 5–7 independent experiments. Statistics were analyzed by unpaired (two-tailed) t-tests, indicating: # p ≤ 0.05 and ## p ≤ 0.01. p-value indicates: ** p ≤ 0.01 by two-way ANOVA with post hoc Tukey’s multiple comparison test. (B,F) Respective cell cycle analysis at that time point were estimated following Nicoletti staining. Data were summarized as mean values ±SEM of 3 independent experiments. (C,G) Cell death rates were further determined by exclusion propidium iodide staining. Data show mean values ±SEM of 3 independent experiments. p-values indicate: * p ≤ 0.05, ** p ≤ 0.01 two-way ANOVA with Tukey’s multiple comparison test. Unpaired (two-tailed) t-tests are additionally indicated: # p ≤ 0.05. (D,H) Total cell death levels were determined by propidium iodide exclusion staining using flow cytometry. Data are summarized as mean values of 3–5 independent experiments. p-value indicate: * p ≤ 0.05, ** p ≤ 0.01 by two-way ANOVA with Tukey’s multiple comparison test. Unpaired (two-tailed) t-tests are additionally indicated: # p ≤ 0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 91 references

Research works printed but not linked: 1

  1. Hussein, 2014, In Efficacy Of Intra-Peritoneal Administration Of Metformin And 5-Fluoruracil In Prevention Of Induced-Colorectal Aberrant Crypt Foci In Mice, Int. J. Pharmacy Pharmaceut Sci., 6, 305

Cited by

See all 34

Metadata

Authors
Hansel, C., Barr, S., Schemann, A. V., Lauber, K., Hess, J., Unger, K., Zitzelsberger, H., Jendrossek, V., & Klein, D.
Affiliations
  • Essen University Hospital (DE)
  • Helmholtz Munich (DE)
Corresponding author
Klein, Diana
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-06-30
Volume
22
Issue
13
Pages
7064
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3174782243
Cited by
33
References
91
Citations by year
2026: 3 · 2025: 9 · 2024: 6 · 2023: 9 · 2022: 5 · 2021: 1
FWCI
2.77
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DuEPublico (University of Duisburg-Essen) (submittedVersion, cc-by)
  • Site cant be reached (submittedVersion, cc-by)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
Funders
  • Bundesministerium für Bildung und Forschung (02NUK047D)
  • Deutsche Forschungsgemeinschaft (GRK1739/2)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
metformin, radiation-induced lung injury, senescence-associated secretory phenotype, senescence, bronchial epithelial cells, radiation pneumonitis, pulmonary fibrosis, vascular permeability, endothelial dysfunction, radiosensitization, tumor control, thoracic radiotherapy, lung epithelial cells
MeSH terms
Animals, Bronchi, Epithelial Cells, Metformin, Radiation Injuries, Experimental, Radiation-Protective Agents, Cellular Senescence, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells. https://app.cochat.ai/papers/10.3390/ijms22137064
The paper
Hansel, C., Barr, S., Schemann, A. V., Lauber, K., Hess, J., Unger, K., Zitzelsberger, H., Jendrossek, V., & Klein, D. (2021). Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22137064

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.